We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Delhi High Court on Friday set aside a government notification in which it had banned Lupin's fixed-dose combination (FDC) drug Gluconorm-30, reported Business Standard.
MSF hopes that Indian Health Ministry will consider issuing a government use license, to encourage manufacturers to continue with phase III clinical trials of PCV13